Global Cardiovascular Devices Market Trends, Forecast Report 2025-2037
Cardiovascular Devices Market size is predicted to expand from USD 62.95 billion to USD 147.68 billion, registering a CAGR of over 6.9% during the forecast timeline, from 2025 to 2037. In the year 2025, the industry size of cardiovascular devices is evaluated at USD 66.37 billion.
The rising of cardiovascular disease risk across followed by an increasing old age population will propel the market growth. As per the World Health Organization, the number of old people aged 60 and above in the U.S. is greater than the number of children less than 5 years of age as of 2020. Also, the number of old people aged 60 and over will double by 2050 to reach 2.1 billion, and the number of old people aged 80 years and above is estimated to grow thrice from 2020 to 2050 and reach 426 million.
In addition, factors such as increase in over-the-counter medicine availability, rising investments, and the expanding number of awareness campaigns on the administration of cardiovascular devices are thought to be driving the global cardiovascular devices market growth. Moreover, an increase in incidences of cardiac diseases such as heart attacks, coronary heart disease, and cardiac arrhythmia will boost the market revenue. According to the Centers for Disease Control and Prevention, heart disease claimed the lives of almost 697,000 Americans in 2020.
Cardiovascular Devices Sector: Growth Drivers and Challenges
Growth Drivers
- Growing Minimal Invasive Medical Procedures – The use of minimally invasive surgery (MIS) in various operations grew rapidly between 2003 to 2018. The application rate of MIS rose from 87% to 92% in cholecystectomy, 21% to 45% in inguinal hernia repair, 9% to 41% in colectomy, 40% to 85% in gastrectomy, and 70% to 90% in Nissen UK.
- Rising Consumption of Tobacco – Tobacco consumption has been linked to poor cardiovascular health, and it is projected to boost the market’s growth. As per the World Health Organization, in 2020, about 22.3% of people across the world consumed tobacco which includes 36.7% of men and 7.8% of women.
- Increasing Compact Devices and Pacemakers – Growing awareness and developing technology have given rise to user-friendly and compact health measuring devices, and it is anticipated to boost the global cardiovascular devices market. For instance, about 30% of the population in China wears connected health devices such as fitness trackers.
- Rising Awareness and Adoption of Remote Healthcare – Remote interactions and online consultations have become one of the primary ways to seek medical advice, especially since the pandemic. As per the estimations, 75% of hospitals in the U.S. associate with patients and concerned physicians through audio and video consultation.
- Increasing Obese Population – Poor lifestyle choices and eating disorders give rise to obesity, which can severely impact a person’s cardiovascular health. The prevalence of obesity in the U.S. in 2020 rose from 30.5% in 2017 to 41.9% in 2020 as per the Centers for Disease Control and Prevention.
Challenges
- Lack of Reimbursement Policies and Medical Insurance – In the United States, those without insurance have less access to healthcare than those with insurance. In 2021, one in 5 people without insurance neglects vital medical care owing of expense. Moreover, nearly, 27.5 million non-elderly people lacked health insurance in 2021 in the United States.
- Unavailability of Investors for R&D
- Lack of Awareness about Devices and their Operation
Cardiovascular Devices Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.9% |
|
Base Year Market Size (2024) |
USD 62.95 billion |
|
Forecast Year Market Size (2037) |
USD 147.68 billion |
|
Regional Scope |
|
Cardiovascular Devices Segmentation
Application (Coronary Artery Diseases, Cardiac Arrhythmia, Heart Failure)
The coronary artery diseases segment is expected to hold largest market share by 2037. In CAD, the coronary arteries, the main blood channels feeding the heart, have difficulty supplying the heart muscle with adequate blood, oxygen, and nutrients, owing to inflammation and cholesterol deposits (plaques) in the major heart arteries. For instance, according to research, it is also a common cause of death in the US, and is estimated to cause over 600,000 deaths yearly, is responsible for 18 million deaths per year worldwide, and is the third biggest cause of mortality.
End User (Hospitals, Specialty Clinics, Others)
The hospital segment is expected to dominate largest market share by 2037, on the back of developed and advanced healthcare infrastructure, improved access to healthcare facilities, growing adoption of innovative healthcare devices, and the rising practice of sedentary lifestyle. Moreover, there has been an increase in the number of hospitals across the globe adopting advanced cardiovascular devices, which is expected to boost the segment growth.
Our in-depth analysis of the global cardiovascular devices market includes the following segments:
|
By Device Type |
|
|
By Application |
|
|
By End User |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportCardiovascular Devices Industry - Regional Synopsis
The North American cardiovascular devices market is predicted to hold majority revenue share by the end of 2037, on the back of rising prevalence of cardiovascular diseases, increasing healthcare expenditure, and growing adoption of advanced devices. Moreover, there has been surging awareness among the people in the region related to the cardiovascular devices available on the market. As per the U.S. Centers for Medicare & Medicaid Services, the national health expenditure rose by 9.7% and reached USD 4.1 trillion in 2020, accounting for USD 12,350 per person.
Companies Dominating the Cardiovascular Devices Landscape
- B Braun Melsungen AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott
- Johnson & Johnson Services, Inc.
- Terumo Corporation
- Edwards Lifesciences Corporation
- Medtronic plc
- Boston Scientific Corporation
- LivaNova PLC
- GE Group
- Siemens Healthcare GmbH
In the News
-
Abbott declared data from five late-breaking presentations showing the advantage of minimally invasive devices to treat heart diseases associated with structural diseases such as value disease or opening in the heart. Also, the data included the findings of Mitraclip and Triclip.
-
GE Group associated with Boston Scientific Corporation to afford end-to-end innovative interventional cardiac care solutions in India. This first Medtech association is to enhance and allow easy cardiac care access to patients and thus focused on the prevailing disease burden in the country.
Author Credits: Radhika Pawar
- Report ID: 3272
- Published Date: Jan 28, 2025
- Report Format: PDF, PPT
